1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Frontier Medicines Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors FMC-376 - Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult | Phase 1 / Phase 2 | Recruiting | Frontier Medicines Corporation | 293 | 2024-02-12 | 2026-10-19 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1)
Australia (1) · South Korea (1) · United States (1)